Burning Rock Biotech Income Statement (2019-2025) | BNR

Income Statement Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Revenue & cost
Revenue (Quarter)
16.27M19.71M19.65M23.12M21.38M19.53M21.74M20.62M20.75M20.17M17.48M17.05M17.40M18.65M18.33M17.27M18.34M20.74M18.49M18.06M
Cost of Revenue (Quarter)
4.53M5.74M5.43M6.58M7.56M7.20M6.47M5.94M6.37M6.32M5.71M6.05M5.53M5.52M5.24M5.01M4.92M5.65M4.60M3.97M
Gross Profit (Quarter)
11.74M13.97M14.21M16.54M13.82M12.33M15.27M14.68M14.38M13.85M11.78M11.00M11.87M13.13M13.09M12.25M13.42M15.09M13.88M14.10M
Operating items
Research & Development (Quarter)
-11.82M-16.74M-10.81M-17.69M-18.85M-13.75M-15.38M-14.62M-13.75M-13.21M-11.47M-10.30M-9.14M-8.94M-7.00M-7.15M-5.57M-6.95M-5.83M-4.99M
Selling, General & Administrative (Quarter)
-17.75M-17.99M-18.05M-22.21M-22.36M-22.44M-20.18M-19.24M-18.64M-9.59M-16.27M-17.12M-13.67M-12.77M-4.68M-5.11M-4.31M-4.39M-4.45M-4.53M
Other Operating Expenses (Quarter)
-8.50M-10.53M-11.85M-16.20M-14.06M-16.02M-12.69M-12.35M-9.47M-10.11M-8.61M-7.01M-6.49M-6.76M-6.90M-11.21M-5.62M-5.31M-5.84M-6.30M
Operating Expenses (Quarter)
-37.98M-45.27M-40.76M-56.10M-55.28M-51.97M-48.25M-46.21M-41.82M-32.57M-36.28M-34.43M-29.30M-28.44M-18.59M-23.48M-15.52M-16.70M-16.15M-15.82M
Operating Income (Quarter)
-26.23M-31.29M-26.55M-39.56M-41.47M-39.63M-32.98M-31.53M-27.44M-18.72M-24.51M-23.43M-17.43M-15.30M-5.50M-11.22M-2.09M-1.60M-2.27M-1.72M
EBIT (Quarter)
-26.51M-31.26M-26.44M-39.56M-41.42M-40.26M-32.98M-31.53M-27.55M-19.38M-24.72M-23.43M-17.43M-15.36M-5.50M-11.22M-2.09M-1.59M-2.25M-1.72M
Non-operating items
Interest & Investment Income (Quarter)
0.12M0.10M0.15M0.16M0.29M0.40M0.28M0.41M0.46M0.72M0.55M0.78M0.56M0.44M0.45M0.25M0.36M0.31M0.24M0.21M
Other Non Operating Income (Quarter)
0.02M0.07M0.00M-0.06M0.05M0.02M-0.03M-0.01M0.09M-0.02M-0.02M0.02M0.06M-0.01M-0.02M0.60M-0.09M0.05M0.00M-0.57M
Net income details
EBT (Quarter)
-26.16M-31.29M-26.39M-39.59M-41.23M-39.12M-32.54M-31.07M-26.91M-18.04M-23.92M-22.70M-16.81M-14.84M-5.07M-10.41M-1.83M-1.32M-2.33M-2.07M
Tax Provisions (Quarter)
-0.25M-0.07M0.18M-0.01M-0.28M-0.06M-0.06M-0.06M-0.15M-0.03M-0.03M-0.03M-0.73M-0.03M-0.03M-0.03M-0.12M
Profit After Tax (Quarter)
-26.16M-31.55M-26.46M-39.41M-41.23M-39.14M-32.54M-31.35M-26.98M-18.10M-23.98M-22.85M-16.84M-14.87M-5.09M-11.14M-1.86M-1.35M-2.35M-2.20M
Income from Continuing Operations (Quarter)
-26.44M-31.02M-26.22M-39.77M-41.18M-39.73M-32.54M-30.80M-26.96M-18.61M-24.07M-22.55M-16.79M-14.87M-5.04M-9.68M-1.80M-1.27M-2.28M-1.95M
Consolidated Net Income (Quarter)
-26.44M-31.02M-26.22M-39.77M-41.18M-39.73M-32.54M-30.80M-26.96M-18.61M-24.07M-22.55M-16.79M-14.87M-5.04M-9.68M-1.80M-1.27M-2.28M-1.95M
Income towards Parent Company (Quarter)
-26.44M-31.02M-26.22M-39.77M-41.18M-39.73M-32.54M-30.80M-26.96M-18.61M-24.07M-22.55M-16.79M-14.87M-5.04M-9.68M-1.80M-1.27M-2.28M-1.95M
Net Income towards Common Stockholders (Quarter)
-26.16M-31.55M-26.46M-39.41M-41.23M-39.14M-32.54M-31.35M-26.98M-18.10M-23.98M-22.85M-16.84M-14.87M-5.09M-11.32M-1.86M-1.35M-2.35M-2.20M
Additional items
EPS (Basic) (Quarter)
-2.90-0.34-12.87-1.93-4.69-0.90
EPS (Weighted Average and Diluted) (Quarter)
-2.90-12.87-1.93-4.69-0.90
Shares Outstanding (Weighted Average) (Quarter)
13.59M17.59M2.44M11.82M2.41M2.44M
Shares Outstanding (Diluted Average) (Quarter)
13.59M2.44M11.82M2.41M2.44M
EBITDA (Quarter)
-24.01M-36.96M-25.50M-43.29M-41.72M-34.70M-29.64M-32.21M-27.80M-16.05M-24.25M-23.27M-16.75M-14.74M-5.67M-10.31M-1.87M-1.39M-2.60M-2.49M
Interest Expenses (Quarter)
-0.08M-0.09M-0.06M-0.01M-0.00M-0.00M
Tax Rate (Quarter)
0.81%0.25%-0.46%0.03%0.89%0.23%0.34%0.26%0.67%0.15%0.18%0.57%6.99%1.69%2.58%1.29%6.03%